Nov 3 2009
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com) Mellow Hope operating subsidiary is in process of finalizing contract details with Hetero Ltd., www.heterodrugs.com one of the largest pharmaceutical manufacturers in India. This contract has been in the works since March 2009, and its finalization promises solid sales boost for Hard to Treat Diseases.
The contract between secures the supply of raw pharmaceutical material for HTDS' Mellow Hope in the range of about 4 million dollars. The contract completion is in final stages, and the shipments are already scheduled. This contract is bound to strengthen present and future sales of the raising pharmaceutical dragon Mellow Hope of Hard to Treat Diseases (HTDS).
In other company news, since September 24, 2009, when Chinese State Food and Drug Administration (SFDA; http://eng.sfda.gov.cn/eng/) granted the H1N1 vaccine licence to Mellow Hope's exclusive business partner Zhejiang Tianyuan Bio-pharmaceutical Co. Ltd., Mellow Hope received inquiries from many potential buyers around the world. At the present, the most promising deals on the horizon include deals with Southeast Asia and Chile. Mellow Hope is the largest exporter of vaccines in China and the H1N1 vaccine licence gives the company a great advantage over the competition. The company expects to make progress announcements on the H1N1 front shortly.
Besides Mellow Hope, Hard to Treat Diseases (HTDS) is also a parent company with operations in Serbia based Slavica Biochem. This company focuses on the enhancement and modification of existing and approved medications as well as on cancer research. This MindUp cancer research has been delivering groundbreaking results on the international level. The company expects to make an announcement with a Canadian based pharmaceutical company on this shortly.
To receive future updates, via email including quarterly newsletters and company updates which may not be newsworthy however important to the reader and followers of the company please sign up today free at www.minamargroup.com/updates
History of endometriosis and fibroids linked to higher long-term risk of early death